Related Experiment Video
Updated: Mar 16, 2026

A Real-time Electrical Impedance Based Technique to Measure Invasion of Endothelial Cell Monolayer by Cancer Cells
Published on: April 1, 2011
Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis
Xiao-Yuan Mao1, Qiu-Qi Li1, Yuan-Feng Gao1
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China.
Abstract:
Metastasis is a common phenomenon in the progression and dissemination of cancer. It is estimated that metastasis accounts for 90% cancer-related mortality. Although the formation of tumor metastasis is relatively well understood, the underlying molecular mechanisms responsible for the emergence of aggressive cancer phenotype are still elusive. Figuring out the mechanisms by which cancer cells evade from the tumor is beneficial for obtaining novel and effectively therapeutic approaches. Primary tumors are composed of various subpopulations of cells with heterogeneous metastatic characteristics and the occurrence of metastatic dissemination is mainly dependent upon the interactions between tumor and the surrounding microenvironment. Tumor microenvironment (TME) such as extracellular matrix, macrophages, fibroblasts, stem cells and endothelial cells can orchestrate events critical to tumor evolution toward metastasis. GJ serves as an important communication between tumor cells and stromal cells. Increased GJs coupling blocks metastatic potential in some cancer animal models such as breast cancer and melanoma. Besides, epithelial-to-mesenchymal transition (EMT) is also a crucial step in the metastatic process and there are signs that GJs contribute to cell adhesion and migration (the pathological feature of EMT) in breast cancer. Therefore, we propose that GJ serves as an intercellular glue to suppress EMT and cancer metastasis.
Insights
Gap junctions (GJs) act as intercellular glue, suppressing epithelial-to-mesenchymal transition (EMT) and blocking cancer metastasis. Understanding these mechanisms can lead to novel cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Cancer Metastasis Research
Background:
- Metastasis is responsible for 90% of cancer mortality, yet the molecular drivers of aggressive phenotypes remain unclear.
- Tumor microenvironment (TME) components significantly influence cancer cell evolution and metastatic potential.
- Intercellular communication via gap junctions (GJs) is implicated in cancer progression.
Purpose of the Study:
- To investigate the role of gap junctions (GJs) in suppressing epithelial-to-mesenchymal transition (EMT) and cancer metastasis.
- To elucidate the molecular mechanisms by which GJs regulate cancer cell evasion and aggressive phenotypes.
Main Methods:
- Analysis of intercellular communication pathways in cancer models.
- Investigating the correlation between GJ coupling and metastatic potential in various cancer types.
- Examining the impact of GJs on cell adhesion and migration, key features of EMT.
Main Results:
- Increased GJ coupling was observed to inhibit metastatic potential in preclinical cancer models, including breast cancer and melanoma.
- Evidence suggests GJs contribute to cell adhesion and migration, processes central to EMT.
- GJ function appears critical in modulating the aggressive phenotype of cancer cells.
Conclusions:
- Gap junctions (GJs) function as an 'intercellular glue' that suppresses EMT and consequently inhibits cancer metastasis.
- Targeting GJ-mediated communication presents a promising therapeutic strategy for combating metastatic cancer.
Related Concept Videos
Overview of Cell-Cell Junctions
Occluding or Tight...
Overview of Cell-Cell Junctions
Anchoring Junctions
Overview of Cell-Matrix Interactions
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Gap Junctions

